Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2010

01-08-2010 | Article

Factors associated with poor adherence to anti-retroviral therapy in patients attending a rural health centre in South Africa

Authors: V. G. Bhat, M. Ramburuth, M. Singh, O. Titi, A. P. Antony, L. Chiya, E. M. Irusen, P. P. Mtyapi, M. E. Mofoka, A. Zibeke, L. A. Chere-Sao, N. Gwadiso, N. C. Sethathi, S. R. Mbondwana, M. Msengana

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2010

Login to get access

Abstract

South Africa has a very high HIV disease burden and proper patient adherence to anti-retroviral therapy (ART) is crucial in achieving optimal treatment outcomes. Factors influencing adherence include demographic and psychosocial factors, medication-related issues and other patient-related matters. This study was carried out in order to determine factors associated with poor compliance to anti-retroviral (ARV) medications in a rural setting. This interview-based descriptive and analytical study was carried out in a health centre where 168 patients who received ARVs were interviewed with pre-structured questionnaires, which covered various important compliance-related aspects. The results showed that 37.5% of the patients were non-adherent. Amongst men, poor adherence was seen in those who were single (48.9%), with tertiary education (60%), in those who consumed alcohol regularly (47.1%) and in those who were unemployed (56.1%). Higher rates of non-adherence in women was associated with being single (36.5%) and in those who used alcohol (60.7%). Medication-related adverse effects were reported in 47% of patients, notably, neuropathy, headache, nausea, loss of memory, diarrhoea and fatigue. Common reasons for missing doses were: being away from home (57.1%), simply forgot (41.3%), side effects (50.8%) and being too busy (49.2%). Poor adherence to ART is an important concern relating to HIV management in our setting and needs to be addressed with more patient-oriented interventions.
Literature
2.
go back to reference Fredlund VG, Nash J (2007) How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis 196:S469–S473CrossRefPubMed Fredlund VG, Nash J (2007) How far should they walk? Increasing antiretroviral therapy access in a rural community in northern KwaZulu-Natal, South Africa. J Infect Dis 196:S469–S473CrossRefPubMed
3.
go back to reference Saliba G, Yeni P (2006) Recent and future therapeutic advances in the management of HIV infection. Pathol Biol 54:545–550CrossRefPubMed Saliba G, Yeni P (2006) Recent and future therapeutic advances in the management of HIV infection. Pathol Biol 54:545–550CrossRefPubMed
4.
go back to reference Holstad MK, Pace JC, De AK, Ura DR (2006) Factors associated with adherence to antiretroviral therapy. J Assoc Nurses AIDS Care 17(2):4–15CrossRefPubMed Holstad MK, Pace JC, De AK, Ura DR (2006) Factors associated with adherence to antiretroviral therapy. J Assoc Nurses AIDS Care 17(2):4–15CrossRefPubMed
5.
go back to reference Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE (2003) Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 37(8):1112–1118CrossRefPubMed Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE (2003) Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 37(8):1112–1118CrossRefPubMed
6.
go back to reference Dietz E, Clum GA, Chung SE, Leonard L, Murphy DA, Perez LV, Harper GW, Ellen JM (2010) Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health 46(3):278–283CrossRefPubMed Dietz E, Clum GA, Chung SE, Leonard L, Murphy DA, Perez LV, Harper GW, Ellen JM (2010) Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities. J Adolesc Health 46(3):278–283CrossRefPubMed
7.
go back to reference Cauldbeck MB, O’Connor C, O’Connor MB, Saunders JA, Rao B, Mallesh VG, Praveen Kumar NK, Mamtha G, McGoldrick C, Laing RB, Satish KS (2009) Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Res Ther 6:7. doi:10.1186/1742-6405-6-7 CrossRefPubMed Cauldbeck MB, O’Connor C, O’Connor MB, Saunders JA, Rao B, Mallesh VG, Praveen Kumar NK, Mamtha G, McGoldrick C, Laing RB, Satish KS (2009) Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Res Ther 6:7. doi:10.​1186/​1742-6405-6-7 CrossRefPubMed
8.
go back to reference Wang H, He G, Li X, Yang A, Chen X, Fennie KP, Williams AB (2008) Self-reported adherence to antiretroviral treatment among HIV-infected people in Central China. AIDS Patient Care STDs 22(1):71–80CrossRefPubMed Wang H, He G, Li X, Yang A, Chen X, Fennie KP, Williams AB (2008) Self-reported adherence to antiretroviral treatment among HIV-infected people in Central China. AIDS Patient Care STDs 22(1):71–80CrossRefPubMed
9.
go back to reference Johnson MO, Charlebois E, Morin SF, Catz SL, Goldstein RB, Remien RH, Rotherham-Borus MJ, Mickalian JD, Kittel L, Samimy-Muzaffar F, Lightfoot MA, Gore-Felton C, Chesney A; NIMH Healthy Living Project Team (2005) Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage 29(2):193–205CrossRefPubMed Johnson MO, Charlebois E, Morin SF, Catz SL, Goldstein RB, Remien RH, Rotherham-Borus MJ, Mickalian JD, Kittel L, Samimy-Muzaffar F, Lightfoot MA, Gore-Felton C, Chesney A; NIMH Healthy Living Project Team (2005) Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage 29(2):193–205CrossRefPubMed
10.
go back to reference Singh N, Berman SM, Swindells S, Justis JC, Mohr JA, Squier C, Wagener MM (1999) Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 29:824–830CrossRefPubMed Singh N, Berman SM, Swindells S, Justis JC, Mohr JA, Squier C, Wagener MM (1999) Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis 29:824–830CrossRefPubMed
11.
go back to reference Garvie PA, Lawford J, Flynn PM, Gaur AH, Belzer M, McSherry GD, Hu C; Pediatric AIDS Clinical Trials Group 1036A Study Team (2009) Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability. J Adolesc Health 44(2):124–132CrossRefPubMed Garvie PA, Lawford J, Flynn PM, Gaur AH, Belzer M, McSherry GD, Hu C; Pediatric AIDS Clinical Trials Group 1036A Study Team (2009) Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability. J Adolesc Health 44(2):124–132CrossRefPubMed
12.
go back to reference Sharma M, Singh RR, Laishram P, Kumar B, Nanao H, Sharma C, Ahmed T (2007) Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment. Int J Drug Policy 18(4):319–325, Epub 2007 Jun 21CrossRefPubMed Sharma M, Singh RR, Laishram P, Kumar B, Nanao H, Sharma C, Ahmed T (2007) Access, adherence, quality and impact of ARV provision to current and ex-injecting drug users in Manipur (India): an initial assessment. Int J Drug Policy 18(4):319–325, Epub 2007 Jun 21CrossRefPubMed
13.
go back to reference Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368(9534):505–510CrossRefPubMed Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, Sutherland D, Vitoria M, Guerma T, De Cock K (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368(9534):505–510CrossRefPubMed
14.
go back to reference Gilbert L, Walker L (2009) “They (ARVs) are my life, without them I’m nothing”—experiences of patients attending a HIV/AIDS clinic in Johannesburg, South Africa. Health Place 15(4):1123–1129, Epub 2009 Jun 27CrossRefPubMed Gilbert L, Walker L (2009) “They (ARVs) are my life, without them I’m nothing”—experiences of patients attending a HIV/AIDS clinic in Johannesburg, South Africa. Health Place 15(4):1123–1129, Epub 2009 Jun 27CrossRefPubMed
15.
go back to reference Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW (2008) The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med 67(2):301–310CrossRefPubMed Nam SL, Fielding K, Avalos A, Dickinson D, Gaolathe T, Geissler PW (2008) The relationship of acceptance or denial of HIV-status to antiretroviral adherence among adult HIV patients in urban Botswana. Soc Sci Med 67(2):301–310CrossRefPubMed
16.
go back to reference Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G (2007) Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 146:564–573PubMed Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G (2007) Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 146:564–573PubMed
17.
go back to reference Kemppainen J, Kim-Godwin YS, Reynolds NR, Spencer VS (2008) Beliefs about HIV disease and medication adherence in persons living with HIV/AIDS in rural southeastern North Carolina. J Assoc Nurses AIDS Care 19(2):127–136CrossRefPubMed Kemppainen J, Kim-Godwin YS, Reynolds NR, Spencer VS (2008) Beliefs about HIV disease and medication adherence in persons living with HIV/AIDS in rural southeastern North Carolina. J Assoc Nurses AIDS Care 19(2):127–136CrossRefPubMed
18.
go back to reference Bhengu BR, Ncama BP, McInerney PA, Wantland DJ, Nicholas PK, Corless IB, McGibbon CA, Davis SM, Nicholas TP, Ros AV (2009) Symptoms experienced by HIV-infected individuals on antiretroviral therapy in KwaZulu-Natal, South Africa. Appl Nurs Res (in press) Bhengu BR, Ncama BP, McInerney PA, Wantland DJ, Nicholas PK, Corless IB, McGibbon CA, Davis SM, Nicholas TP, Ros AV (2009) Symptoms experienced by HIV-infected individuals on antiretroviral therapy in KwaZulu-Natal, South Africa. Appl Nurs Res (in press)
19.
go back to reference Karcher H, Omondi A, Odera J, Kunz A, Harms G (2007) Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 12(5):687–694PubMedCrossRef Karcher H, Omondi A, Odera J, Kunz A, Harms G (2007) Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 12(5):687–694PubMedCrossRef
20.
go back to reference Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO, Saag MS (2002) Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS Care 14(5):607–617CrossRefPubMed Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO, Saag MS (2002) Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS Care 14(5):607–617CrossRefPubMed
21.
go back to reference Stout BD, Leon MP, Niccolai LM (2004) Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDs 18(5):297–304CrossRefPubMed Stout BD, Leon MP, Niccolai LM (2004) Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDs 18(5):297–304CrossRefPubMed
22.
go back to reference Fong OW, Ho CF, Fung LY, Lee FK, Tse WH, Yuen CY, Sin KP, Wong KH (2003) Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. HIV Med 4:133–138CrossRefPubMed Fong OW, Ho CF, Fung LY, Lee FK, Tse WH, Yuen CY, Sin KP, Wong KH (2003) Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. HIV Med 4:133–138CrossRefPubMed
23.
go back to reference Södergård B, Halvarsson M, Tully MP, Mindouri S, Nordström ML, Lindbäck S, Sönnerborg A, Lindblad AK (2006) Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther 31(6):605–616CrossRefPubMed Södergård B, Halvarsson M, Tully MP, Mindouri S, Nordström ML, Lindbäck S, Sönnerborg A, Lindblad AK (2006) Adherence to treatment in Swedish HIV-infected patients. J Clin Pharm Ther 31(6):605–616CrossRefPubMed
24.
go back to reference Skhosana NL, Struthers H, Gray GE, Mclntyre JA (2006) HIV disclosure and other factors that impact on adherence to antiretroviral therapy: the case of Soweto, South Africa. Afr J AIDS Res 5(1):17–26 Skhosana NL, Struthers H, Gray GE, Mclntyre JA (2006) HIV disclosure and other factors that impact on adherence to antiretroviral therapy: the case of Soweto, South Africa. Afr J AIDS Res 5(1):17–26
25.
go back to reference Catz SL, Heckman TG, Kochman A, DiMarco M (2001) Rates and correlates of HIV treatment adherence among late middle-aged and older adults living with HIV disease. Psychol Health Med 6:47–58CrossRef Catz SL, Heckman TG, Kochman A, DiMarco M (2001) Rates and correlates of HIV treatment adherence among late middle-aged and older adults living with HIV disease. Psychol Health Med 6:47–58CrossRef
26.
go back to reference Amico KR, Konkle-Parker DJ, Cornman DH, Barta WD, Ferrer R, Norton WE, Trayling C, Shuper P, Fisher JD, Fisher WA (2007) Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi. AIDS Care 19(10):1210–1218CrossRefPubMed Amico KR, Konkle-Parker DJ, Cornman DH, Barta WD, Ferrer R, Norton WE, Trayling C, Shuper P, Fisher JD, Fisher WA (2007) Reasons for ART non-adherence in the Deep South: adherence needs of a sample of HIV-positive patients in Mississippi. AIDS Care 19(10):1210–1218CrossRefPubMed
27.
go back to reference Chander G, Lau B, Moore RD (2006) Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 43(4):411–417CrossRefPubMed Chander G, Lau B, Moore RD (2006) Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr 43(4):411–417CrossRefPubMed
28.
go back to reference Aspeling HE, van Wyk NC (2008) Factors associated with adherence to antiretroviral therapy for the treatment of HIV-infected women attending an urban care facility. Int J Nurs Pract 14:3–10PubMed Aspeling HE, van Wyk NC (2008) Factors associated with adherence to antiretroviral therapy for the treatment of HIV-infected women attending an urban care facility. Int J Nurs Pract 14:3–10PubMed
29.
go back to reference Murphy DA, Johnston Roberts K, Hoffman D, Molina A, Lu MC (2003) Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 15(2):217–230CrossRefPubMed Murphy DA, Johnston Roberts K, Hoffman D, Molina A, Lu MC (2003) Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 15(2):217–230CrossRefPubMed
30.
go back to reference Leserman J, Ironson G, O’Cleirigh C, Fordiani JM, Balbin E (2008) Stressful life events and adherence in HIV. AIDS Patient Care STDs 22(5):403–411CrossRefPubMed Leserman J, Ironson G, O’Cleirigh C, Fordiani JM, Balbin E (2008) Stressful life events and adherence in HIV. AIDS Patient Care STDs 22(5):403–411CrossRefPubMed
31.
go back to reference Villes V, Spire B, Lewden C, Perronne C, Besnier JM, Garré M, Chêne G, Leport C, Carrieri MP, Le Moings V; ANRS CO-8 APROCO-COPILOTE Study Group (2007) The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antivir Ther 12(7):1067–1074PubMed Villes V, Spire B, Lewden C, Perronne C, Besnier JM, Garré M, Chêne G, Leport C, Carrieri MP, Le Moings V; ANRS CO-8 APROCO-COPILOTE Study Group (2007) The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antivir Ther 12(7):1067–1074PubMed
32.
go back to reference Wouters E, Van Damme W, Van Loon F, van Rensburg D, Meulemans H (2009) Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. Soc Sci Med 69(8):1177–1185, Epub 2009 Aug 18CrossRefPubMed Wouters E, Van Damme W, Van Loon F, van Rensburg D, Meulemans H (2009) Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. Soc Sci Med 69(8):1177–1185, Epub 2009 Aug 18CrossRefPubMed
33.
go back to reference Wessels X, Nattrass N, Rivett U (2007) Improving the efficiency of monitoring adherence to antiretroviral therapy at primary health care level: a case study of the introduction of electronic technologies in Guguletu, South Africa. Dev South Afr 24(4):607–621CrossRef Wessels X, Nattrass N, Rivett U (2007) Improving the efficiency of monitoring adherence to antiretroviral therapy at primary health care level: a case study of the introduction of electronic technologies in Guguletu, South Africa. Dev South Afr 24(4):607–621CrossRef
Metadata
Title
Factors associated with poor adherence to anti-retroviral therapy in patients attending a rural health centre in South Africa
Authors
V. G. Bhat
M. Ramburuth
M. Singh
O. Titi
A. P. Antony
L. Chiya
E. M. Irusen
P. P. Mtyapi
M. E. Mofoka
A. Zibeke
L. A. Chere-Sao
N. Gwadiso
N. C. Sethathi
S. R. Mbondwana
M. Msengana
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0949-4

Other articles of this Issue 8/2010

European Journal of Clinical Microbiology & Infectious Diseases 8/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.